Stock screener

NSPR

Conviction 34HealthcareScan · Mon, Aug 10, 2026
NSPR$0.7969+7.57%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
2
Vol MA14 62.89K
May 11May 28Jun 16Jul 6Jul 23Aug 10
InspireMD, Inc.SURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.inspiremd.com
Price0.7969
Change+7.57%
Gap+1.58%
Rel volume6.34×
Avg volume51.94K
Avg $ vol37.63K
SMA 200.7037
SMA 500.7404
SMA 2001.44
Price vs 50+7.63%
Price vs 200-44.47%
MA stackmixed
50/200 cross
Supertrendup · 0.6691
RSI (14)66
MACD hist0.02
MACD cross
Stoch %K / %D68 / 83
ADX (14)38
+DI / −DI27 / 16
RSI divergence
MACD divergence
ATR %+5.89%
ADR %4.81%
52w high2.58
52w low0.6500
From 52w high-69.11%
Above 52w low+22.60%
New 52w highNo
SqueezeOn · 25d
Bollinger width17.11%
%B1.27
Donchian pos67.95%
Donchian high0.8662
Donchian low0.6500
AVWAP (52w high)1.45
vs AVWAP high-44.91%
AVWAP (52w low)0.7114
vs AVWAP low+12.02%
OBV trendUp
Chaikin MF (20)0.04
Today vs 20d6.34×
Avg vol (14d)62.89K
Avg vol (20d)51.94K
Avg $ vol (20d)37.63K
Market cap37.33M
RS 3m (vs SPY)-41.84%
RS 6m (vs SPY)-68.94%
RS line new highNo
Trend template1/8
Technical rank36.8
1 week+17.02%
1 month+10.68%
3 months-30.70%
6 months-54.20%
1 year-66.66%
YTD-57.16%
P/E-0.77
P/B0.86
P/S4.16
P/FCF-1.02
EPS-0.7600
Div yield
ROE-111.85%
ROA-86.39%
Debt/Eq0.09
Current5.15
EV/EBITDA-0.60
Gross margin29.50%
Net margin-543.33%
Rev growth28.11%
EPS growth-52.43%
Price target
Target upside
Analyst rating
Institutional
Ent. value29.74M
Revenue3.4M
Net income-13.69M
Gross profit687K
Free cash flow-36.77M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out46.84M
Employees127
ListedFri, Aug 22, 1997
Free float33.61M
Float %71.7%
Short interest76.87K
Days to cover0.9d
Short volume78.1%
Squeeze score40 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction34 / 100
Pattern quality
Tech rank36.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance0.7447
Support0.6350
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NSPR

All disclosures →
No recent disclosed trades by Congress in NSPR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NSPR · 1 buy · 8 sells

InsiderSideShares
Stuka Paul
Director · Common Stock · 2026-05-27
Other
Stuka Paul
Director · Common Stock · 2026-05-27
Buy20K
Gleason Shane Thomas
Chief Commercial Officer · Common Stock · 2026-05-19
Sell22.78K
Gleason Shane Thomas
Chief Commercial Officer · Common Stock · 2026-02-02
Sell2.94K
Gleason Shane Thomas
Chief Commercial Officer · Common Stock · 2025-05-30
Sell7.19K
Gleason Shane Thomas
Chief Commercial Officer · Common Stock · 2025-05-29
Sell3.76K
Gleason Shane Thomas
Chief Commercial Officer · Common Stock · 2025-05-27
Sell1.57K
Gleason Shane Thomas
Chief Commercial Officer · Common Stock · 2025-05-23
Sell2.48K
Gleason Shane Thomas
Chief Commercial Officer · Common Stock · 2025-02-25
Sell10K
Gleason Shane Thomas
Chief Commercial Officer · Common Stock · 2025-02-04
Sell5.13K

SEC filings

EDGAR filings in NSPR · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.